contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment CompanyTagList on Company {
  pageUrl
  name
  viewerIsFollowing
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    ...CompanyTagList
    id
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      defaultInstrument {
        isin
        id
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
      id
    }
    createdAt
    ... on Video {
      liveTime
    }
    ... on Webcast {
      liveTime
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    id
    name
    pageUrl
    viewerIsFollowing
    defaultInstrument {
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


braincool-receives-orders-for-consumable-products-to-a-value-of-sek-8-million

__typename

title

isPremium

lang

htmlBody

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

BrainCool operates in the medical technology sector. The company develops products for medical cooling of the brain. The technology is developed as cooling pads that are applied to different parts of the patient's body, where the system controls body temperature. The products are used in the treatment of various serious conditions including stroke, cardiac arrest, as well as concussion and migraine. BrainCool was founded in 2010 and is headquartered in Lund.

BrainCool

BrainCool (publ) today announced that the company has received orders for BrainCoool™ System consumables totaling SEK 8 million. Most of these orders originate from the agreement and collaboration...

<div class="mfn-preamble"><p><strong>BrainCool (publ) today announced that the company has received orders for BrainCoool™ System consumables totaling SEK 8 million. Most of these orders originate from the agreement and collaboration with ZOLL® in the US and Europe, with additional orders coming from the company's distributors in South Korea and Vietnam. The orders are set to be delivered during the first six months of 2025.</strong></p></div><div class="mfn-body"><p>BrainCool™ System offers precision temperature management of the body, for example, to improve survival and reduce permanent disability in people suffering from sudden cardiac arrest or stroke.<strong> </strong>The system utilizes cooling pads designed for minimal discomfort to reach target temperatures. Furthermore, the cooling pads can be repositioned during treatment, which decreases the risk of skin damage and lessens the workload for hospital staff. As the number of operating systems in clinics grows, the continuous use of pads leads to increasing revenues over time. In 2024, BrainCool supplied nearly 10,000 consumables, compared to around 5,500 in 2023.</p><p>“<em>We are encouraged that the cooperation with ZOLL® continues to develop according to plan. The orders presented today clearly signal that the BrainCool™ Systems in place at hospitals are being incorporated into clinical practice and that hospital staff are confident in the clinical benefit they provide. Furthermore, we are glad to have received additional orders from South Korea and Vietnam, as we see great potential in the commercial growth also in this region</em>,” said Jon Berg, CEO of BrainCool.</p></div><div class="mfn-footer mfn-46d5b376c4f5"><p><strong class="mfn-heading-1">Contact</strong><br><strong>For more information</strong><br>Jon Berg - CEO<br>+46 722 50 91 19<br>E-mail: jon.berg@braincool.se</p></div><div class="mfn-footer mfn-about mfn-65972121fba8"><p><strong class="mfn-heading-1">About Us</strong><br>BrainCool AB (publ) is an innovative medical device company that develops, markets, and sells leading medical cooling systems for indications and areas with significant medical benefits within the healthcare sector. BrainCool AB (publ) is based in Lund, Sweden, and its share is listed on Nasdaq First North Growth Market, named “BRAIN”.<br>Eminova Fondkommission AB is the company’s Certified Adviser.</p></div><div class="mfn-footer mfn-attachment mfn-attachment-general"><p><strong class="mfn-heading-1">Attachments</strong><br><a rel="noopener" href="https://storage.mfn.se/98fa1383-cc3e-4374-863f-a8c3454b4a14/braincool-receives-orders-for-consumable-products-to-a-value-of-sek-8-million.pdf" class="mfn-generated mfn-primary">BrainCool receives orders for consumable products to a value of SEK 8 million</a></p></div>